Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,293 | 11 | 94.6% |
| Travel and Lodging | $820.44 | 2 | 3.0% |
| Food and Beverage | $564.53 | 6 | 2.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75.00 | 1 | 0.3% |
| Education | $31.10 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PTC Therapeutics, Inc. | $18,093 | 9 | $0 (2023) |
| Sarepta Therapeutics, Inc. | $9,238 | 7 | $0 (2021) |
| Genentech, Inc. | $346.57 | 3 | $0 (2024) |
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $75.00 | 1 | $0 (2021) |
| CATALYST PHARMACEUTICALS, INC. | $31.10 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.92 | 2 | Genentech, Inc. ($128.82) |
| 2023 | $4,898 | 2 | PTC Therapeutics, Inc. ($4,810) |
| 2022 | $5,124 | 2 | PTC Therapeutics, Inc. ($4,995) |
| 2021 | $8,988 | 6 | PTC Therapeutics, Inc. ($4,713) |
| 2020 | $3,575 | 3 | PTC Therapeutics, Inc. ($3,575) |
| 2018 | $5,038 | 6 | Sarepta Therapeutics, Inc. ($5,038) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Education | Cash or cash equivalent | $31.10 | General |
| Category: NEUROLOGY | ||||||
| 06/05/2024 | Genentech, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $128.82 | General |
| Category: Neurology | ||||||
| 12/15/2023 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,810.00 | General |
| 06/29/2023 | Genentech, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $88.40 | General |
| Category: Neurology | ||||||
| 12/15/2022 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Consulting Fee | Cash or cash equivalent | $4,995.00 | General |
| Category: DMD | ||||||
| 06/15/2022 | Genentech, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $129.35 | General |
| Category: Neurology | ||||||
| 12/13/2021 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $75.00 | General |
| 11/17/2021 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,543.75 | General |
| 10/26/2021 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,543.75 | General |
| 09/13/2021 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 06/28/2021 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 02/08/2021 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 11/10/2020 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,462.50 | General |
| 08/25/2020 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| 06/26/2020 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $487.50 | General |
| 08/29/2018 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Travel and Lodging | Cash or cash equivalent | $528.11 | General |
| Category: Genetic Disease | ||||||
| 08/21/2018 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Genetic Disease | ||||||
| 08/04/2018 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Travel and Lodging | Cash or cash equivalent | $292.33 | General |
| Category: Genetic Disease | ||||||
| 08/04/2018 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Food and Beverage | Cash or cash equivalent | $149.32 | General |
| Category: Genetic Disease | ||||||
| 08/04/2018 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Food and Beverage | Cash or cash equivalent | $34.99 | General |
| Category: Genetic Disease | ||||||
| 08/04/2018 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Food and Beverage | Cash or cash equivalent | $33.65 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 210 | 253 | $44,694 | $8,744 |
| 2022 | 6 | 258 | 313 | $57,061 | $11,075 |
| 2021 | 7 | 313 | 371 | $68,421 | $12,731 |
| 2020 | 6 | 284 | 337 | $57,355 | $10,879 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 31 | 31 | $9,114 | $1,770 | 19.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 25 | 25 | $9,850 | $1,683 | 17.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 83 | 124 | $7,070 | $1,570 | 22.2% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 17 | 17 | $8,368 | $1,489 | 17.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 32 | 34 | $4,899 | $1,135 | 23.2% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 22 | 22 | $5,393 | $1,097 | 20.3% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 54 | 54 | $15,876 | $3,005 | 18.9% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 39 | 39 | $15,292 | $2,975 | 19.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 106 | 160 | $10,540 | $2,122 | 20.1% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 16 | 16 | $7,827 | $1,499 | 19.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 32 | 33 | $5,796 | $1,156 | 19.9% |
| 95887 | Needle measurement of electrical activity in trunk or head muscles | Facility | 2022 | 11 | 11 | $1,730 | $317.82 | 18.4% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2021 | 52 | 53 | $15,582 | $3,117 | 20.0% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2021 | 119 | 176 | $11,792 | $2,393 | 20.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 28 | 28 | $10,976 | $2,261 | 20.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2021 | 23 | 23 | $11,247 | $1,768 | 15.7% |
| 95908 | Nerve transmission studies, 3-4 studies | Facility | 2021 | 34 | 34 | $8,364 | $1,448 | 17.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 41 | 41 | $7,380 | $1,276 | 17.3% |
| 95887 | Needle measurement and recording of electrical activity of head or trunk muscles | Facility | 2021 | 16 | 16 | $3,080 | $467.68 | 15.2% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2020 | 51 | 51 | $14,994 | $2,793 | 18.6% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2020 | 33 | 33 | $12,936 | $2,630 | 20.3% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2020 | 110 | 161 | $10,787 | $2,212 | 20.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 44 | 46 | $8,280 | $1,458 | 17.6% |
| 95908 | Nerve transmission studies, 3-4 studies | Facility | 2020 | 33 | 33 | $8,118 | $1,426 | 17.6% |
| 95887 | Needle measurement and recording of electrical activity of head or trunk muscles | Facility | 2020 | 13 | 13 | $2,240 | $360.24 | 16.1% |
About Dr. William Burnette, MD
Dr. William Burnette, MD is a Neuromuscular Medicine healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265579338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Burnette, MD has received a total of $27,784 in payments from pharmaceutical and medical device companies, with $159.92 received in 2024. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($26,293).
As a Medicare-enrolled provider, Burnette has provided services to 1,065 Medicare beneficiaries, totaling 1,274 services with total Medicare billing of $43,428. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Neuromuscular Medicine
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Nashville, TN
- Active Since 01/30/2007
- Last Updated 03/21/2022
- Taxonomy Code 2084N0008X
- Entity Type Individual
- NPI Number 1265579338
Products in Payments
- EXONDYS 51 (Drug) $5,038
- EMFLAZA (Drug) $4,995
- Evrysdi (Drug) $346.57
- AGAMREE (Drug) $31.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neuromuscular Medicine Doctors in Nashville
Dr. Darian Reddick, Md, MD
Neuromuscular Medicine — Payments: $8,760
John Sturgis
Neuromuscular Medicine — Payments: $279.90
Shaily Patel, Md, MD
Neuromuscular Medicine — Payments: $10.93
Jane Howard, Md, MD
Neuromuscular Medicine
Lauren Herrera
Neuromuscular Medicine
Alexander Robison, Lmt, LMT
Neuromuscular Medicine